These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3688425)

  • 1. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class.
    Popieniek PH; Pratt RF
    Anal Biochem; 1987 Aug; 165(1):108-13. PubMed ID: 3688425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of alpha- and beta-avoparcin with bacterial cell-wall receptor-mimicking peptides studied by electrospray ionization mass spectrometry.
    van de Kerk-van Hoof A; Heck AJ
    J Antimicrob Chemother; 1999 Nov; 44(5):593-9. PubMed ID: 10552974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine.
    Good VM; Gwynn MN; Knowles DJ
    J Antibiot (Tokyo); 1990 May; 43(5):550-5. PubMed ID: 2113517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
    Cooper MA; Fiorini MT; Abell C; Williams DH
    Bioorg Med Chem; 2000 Nov; 8(11):2609-16. PubMed ID: 11092546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermochemistry of the interaction between peptides and vancomycin or ristocetin.
    Rodríguez-Tebar A; Vázquez D; Pérez Velázquez JL; Laynez J; Wadsö I
    J Antibiot (Tokyo); 1986 Nov; 39(11):1578-83. PubMed ID: 3793627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the origins of a cooperative binding energy of dimerization.
    Williams DH; Maguire AJ; Tsuzuki W; Westwell MS
    Science; 1998 May; 280(5364):711-4. PubMed ID: 9563941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
    Fesik SW; Armitage IM; Ellestad GA; McGahren WJ
    Mol Pharmacol; 1984 Mar; 25(2):281-6. PubMed ID: 6700574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase enzyme-receptor assay (SPERA): a competitive-binding assay for glycopeptide antibiotics of the vancomycin class.
    Corti A; Rurali C; Borghi A; Cassani G
    Clin Chem; 1985 Oct; 31(10):1606-10. PubMed ID: 2931213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.
    Xing B; Jiang T; Wu X; Liew R; Zhou J; Zhang D; Yeow EK
    Chemistry; 2011 Dec; 17(50):14170-7. PubMed ID: 22083883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence assay to predict activity of the glycopeptide antibiotics.
    Vimberg V; Gazak R; Szűcs Z; Borbás A; Herczegh P; Cavanagh JP; Zieglerova L; Závora J; Adámková V; Balikova Novotna G
    J Antibiot (Tokyo); 2019 Feb; 72(2):114-117. PubMed ID: 30504918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct fluorescence polarization assay for the detection of glycopeptide antibiotics.
    Yu L; Zhong M; Wei Y
    Anal Chem; 2010 Aug; 82(16):7044-8. PubMed ID: 20704393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification and inhibition of vancomycin group antibiotics by formaldehyde and acetaldehyde.
    Heck AJ; Bonnici PJ; Breukink E; Morris D; Wills M
    Chemistry; 2001; 7(4):910-6. PubMed ID: 11288883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.
    Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M
    J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic analysis of the interaction of the antibiotic teicoplanin and its aglycone with cell-wall peptides.
    Arriaga P; Laynez J; Menendez M; Cañada J; Garcia-Blanco F
    Biochem J; 1990 Jan; 265(1):69-77. PubMed ID: 2137332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting closer to the real bacterial cell wall target: biomolecular interactions of water-soluble lipid II with glycopeptide antibiotics.
    Vollmerhaus PJ; Breukink E; Heck AJ
    Chemistry; 2003 Apr; 9(7):1556-65. PubMed ID: 12658654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics.
    Pitkin DH; Mico BA; Sitrin RD; Nisbet LJ
    Antimicrob Agents Chemother; 1986 Mar; 29(3):440-4. PubMed ID: 2940973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin.
    Cheng M; Ziora ZM; Hansford KA; Blaskovich MA; Butler MS; Cooper MA
    Org Biomol Chem; 2014 Apr; 12(16):2568-75. PubMed ID: 24608916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The formation of heterodimers by vancomycin group antibiotics.
    Staroske T; O'Brien DP; Jørgensen TJ; Roepstorff P; Williams DH; Heck AJ
    Chemistry; 2000 Feb; 6(3):504-9. PubMed ID: 10747417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.